glp-1 heart muscle Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight GLP-1 Receptor Agonists and Myocardial

It is well known that SDF-1 is an extremely important chemokine for EPC mobilization from bone to circulation and EPC homing from circulation to ischemic area [33-36]

but was recently withdrawn as data indicated that it increased cancer risk

Koehler JA, Baggio LL, Lamont BJ, Ali S, and Drucker DJ

Patients who implement calorie reduction and increase their activity levels typically experience faster and more pronounced benefits than those relying on medication alone

B12 deficiency prevention during GLP-1 therapy This is the more serious reason for B12 inclusion, and it is one that many patients are not informed about